| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Dividendenbekanntmachungen (03.03.2026) | 5.666 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCENT GROUP LIMITED AU000000AX19 0,0325 AUD 0,0197 EUR ANALOG DEVICES INC US0326541051 1,1 USD 0,9411 EUR AUTOLIV INC SDR SE0021309614 0... ► Artikel lesen | |
| 22.02. | ORIGIN ENERGY LIMITED: Appendix 3Y x 2 | - | ASX | ||
| 20.02. | ORIGIN ENERGY LIMITED: Notification regarding unquoted securities - ORG | - | ASX | ||
| 16.02. | Buy, hold, sell: Orica, Origin Energy, and Pro Medicus shares | 2 | The Motley Fool Australia | ||
| 13.02. | Why AMP, GQG, NextDC, and Origin Energy shares are racing higher today | 1 | The Motley Fool Australia | ||
| 12.02. | Origin Energy H1 Profit, Revenue Down | 290 | AFX News | CANBERA (dpa-AFX) - Origin Energy Limited (OGFGF.PK) on Thursday reported lower earnings for the first half, mainly due to decline in revenue compared with the prior year.Profit before tax fell... ► Artikel lesen | |
| ORIGIN ENERGY LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 12.02. | Why ANZ, CBA, Northern Star, and Origin Energy shares are charging higher today | 9 | The Motley Fool Australia | ||
| 12.02. | Origin Energy HY26 slides: Lower profits offset by improved cash flow and strategic moves | 3 | Investing.com | ||
| 11.02. | Origin Energy posts $557m half-year profit and upgrades guidance | 3 | The Motley Fool Australia | ||
| 11.02. | ORIGIN ENERGY LIMITED: ORG Half Year Results for the period ended 31 December 2025 | - | ASX | ||
| 11.02. | ORIGIN ENERGY LIMITED: Origin Reports Half Year Results | - | ASX | ||
| 11.02. | ORIGIN ENERGY LIMITED: Investor Presentation for Half Year Results | - | ASX | ||
| 11.02. | ORIGIN ENERGY LIMITED: Dividend/Distribution - ORG | 13 | ASX | ||
| 10.02. | Buy, hold, sell: Bubs, Origin Energy, 4D Medical shares | 2 | The Motley Fool Australia | ||
| 08.02. | Are Origin Energy shares a buy, hold or sell before earnings results? | 2 | The Motley Fool Australia | ||
| 05.02. | Origin Energy Forgoes Eraring Safety-Net Funds | 3 | Finance News Network | ||
| 30.01. | Origin Energy's APLNG Fields Show Stability | 2 | Finance News Network | ||
| 29.01. | ORIGIN ENERGY LIMITED: December 2025 Quarterly Report | - | ASX | ||
| 20.01. | Origin Energy To Extend Eraring Power Station Operations Until April 2029 | 313 | AFX News | CANBERA (dpa-AFX) - Origin Energy Ltd. (OGFGY, ORG.AX) announced on Tuesday that it has advised the Australian Energy Market Operator that it will extend operations at its four-unit Eraring... ► Artikel lesen | |
| 20.01. | Hot Stocks: Fletcher Building, Origin Energy, Telix Pharmaceuticals, True North Copper | 8 | Finance News Network |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 82,01 | -0,12 % | Medtronic, GE HealthCare expand strategic alliance | ||
| THERMO FISHER | 441,70 | +0,27 % | THERMO FISHER SCIENTIFIC INC. - 10-K, Annual Report | ||
| BECTON DICKINSON | 147,95 | +0,44 % | BD (Becton, Dickinson and Company): BD Advances Iliac Artery Treatment Across the European Union | FRANKLIN LAKES, N.J., March 5, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking... ► Artikel lesen | |
| DEXCOM | 62,85 | +0,34 % | Kevin Sayer returns from leave of absence to chair Dexcom board | ||
| RESMED | 221,90 | -0,31 % | Resmed, Inc.: Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach | Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
53% of people surveyed rank sleep as the most important behavior for a long... ► Artikel lesen | |
| DAVITA | 129,80 | -2,33 % | DaVita Celebrates 20 Years on Fortune's List of World's Most Admired Companies | Two decades of recognition underscore leadership in clinical innovation, employer strategy NORTHAMPTON, MA / ACCESS Newswire / February 26, 2026 / DaVita, a leading provider of comprehensive kidney... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 67,62 | -0,38 % | GE HealthCare inks 10-year Care Alliance with UCSF Health | ||
| ORGANON | 5,836 | -1,05 % | KDventures AB: KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos' drug candidate for PCOS | STOCKHOLM, Sweden, March 3, 2026. KDventures AB (Nasdaq Stockholm: KDV) today announces that Organon has discontinued the development of a preclinical drug candidate for polycystic ovarian syndrome... ► Artikel lesen | |
| COOPER COMPANIES | 70,50 | 0,00 % | Cooper Companies' Earnings Outlook | ||
| LANTHEUS | 67,18 | +0,63 % | Lantheus Holdings, Inc.: Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update | Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025GAAP fully diluted earnings per share of $0.82 and $3.41 for the fourth quarter and full year 2025Adjusted... ► Artikel lesen | |
| NATERA | 175,00 | 0,00 % | Signatera Oncology Test Drives Natera's (NTRA) Growth | ||
| BRIGHTSPRING HEALTH SERVICES | 41,960 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS | 46,920 | -2,62 % | DEUTSCHE BANK RESEARCH stuft Fresenius SE auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Falko Friedrichs lobte in seiner am Donnerstag vorliegenden... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,380 | -3,12 % | SIEMENS HEALTHINEERS AG stürzt ab - ich rieche Gefahr! | ||
| FRESENIUS MEDICAL CARE | 39,420 | +0,69 % | BARCLAYS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für FMC von 47,50 auf 46,50 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Das Wachstum der Behandlungszahlen... ► Artikel lesen |